Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
American Journal of Hematology|March 22, 2006
False-negative factor V Leiden genetic testing in a patient with recurrent deep venous thrombosisEdward N Libby, Jessica K Booker, Margaret L Gulley, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 7, 2009
The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephalyElizabeth A Varga, Matthew Pastore, Thomas Prior, et al.
Research and Practice in Thrombosis and Haemostasis|July 7, 2023
Advanced practice provider-led clinic for care transitions in newly diagnosed venous thromboembolism: establishment and utilizationCassiopeia Frank, Raj Kasthuri, Nigel S Key, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
Phase II trial of alfimeprase, a novel-acting fibrin degradation agent, for occluded central venous access devicesStephan Moll, Peter Kenyon, Luigi Bertoli, et al.
The American Journal of Medicine|December 22, 2019
Safety and Efficacy of High-Dose Unfractionated Heparin Versus High-Dose Enoxaparin for Venous Thromboembolism Prevention in Morbidly Obese Hospitalized PatientsS Walker Mason, Alexandra Barber, Emily Jones, et al.
International Journal of Spine Surgery|September 28, 2020
An Evidence-Based Algorithm for Determining Venous Thromboembolism Prophylaxis After Degenerative Spinal SurgeryJoshua A Shapiro, Matthew R Stillwagon, Alexander G Padovano, et al.
Research and Practice in Thrombosis and Haemostasis|March 18, 2021
Vascular thromboembolic events following COVID-19 hospital discharge: Incidence and risk factorsHarish Eswaran, Jamie A Jarmul, Amy W Shaheen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 28, 2004
Percutaneous coronary intervention in a patient with immune thrombocytopenia purpuraGeorge A Stouffer, Jana Hirmerova, Stephan Moll, et al.
Leukemia & Lymphoma|April 11, 2017
Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohortDamon E Houghton, Nigel S Key, Neil A Zakai, et al.
The American Journal of Medicine|September 4, 2012
Incidence of thrombocytopenia among patients receiving heparin venous thromboembolism prophylaxisTracy Y Wang, Emily F Honeycutt, Victor F Tapson, et al.
Pageof 9